Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Modulus Therapeutics, Inc

Advertisement

Advertisement

2101 N 34th St Ste 195
Seattle, WA 98103

Modulus Therapeutics, Inc is a biotechnology company based in Seattle, WA. Specializing in the development of innovative therapies, the company focuses on researching and creating cutting-edge solutions for various medical conditions.

With a team of dedicated scientists and researchers, Modulus Therapeutics, Inc is committed to advancing the field of biotechnology through its groundbreaking work. The company's mission is to improve patient outcomes and contribute to the advancement of healthcare through its novel therapeutic approaches.

Generated from their business information

Also at this address

Suzanne Roedel DDS

State Farm Insurance

Linders, Kendra, Nickelle

Consumer Opinion Services Inc

Own this business?
Claim it
See a problem?

You might also like

Business services, nec, nec, Nonresidential construction, nec, nec, Drugs acting on the respiratory system

Lumen Bioscience

Lumen Bioscience is a Seattle-based biotechnology company specializing in the development of innovative solutions for the healthcare industry. With a focus on scientific research and job opportunities, Lumen is dedicated to advancing the field of bioscience through its cutting-edge technologies and commitment to excellence. Driven by a team of experts, Lumen Bioscience aims to revolutionize the healthcare landscape by offering novel products and services that address the needs of both researchers and the general public. Through their primary science pipeline and dedication to privacy and ethical practices, Lumen is poised to make a significant impact in the field of biotechnology.Generated from the website

Proniras Corp

Proniras Corporation is a specialty pharmaceutical company based in Seattle, WA, dedicated to developing innovative therapies for individuals battling addiction and seizure disorders. With a strong focus on research and development, Proniras Corporation has secured significant grants and contracts, including a prestigious award from the National Institute on Drug Abuse, to pursue effective treatments for opioid withdrawal and nerve agent-induced seizures.Generated from the website
Sound Pharmaceutical
Biotechnical research, noncommercial, Drugs and drug proprietaries

Sound Pharmaceutical

Sound Pharmaceuticals, Inc. (SPI) is a privately held biopharmaceutical company based in Seattle, WA. They are dedicated to developing novel therapeutics that aim to prevent and treat various forms of hearing loss, including sensorineural hearing loss and tinnitus. With an estimated 50 million Americans affected by these conditions, SPI's groundbreaking research and development efforts have the potential to significantly impact the lives of millions. Driven by the mission to address the lack of FDA-approved drugs for inner ear disorders, SPI is at the forefront of pioneering treatments for hearing loss and tinnitus. Their innovative approach and commitment to advancing the field of neurotology have positioned them as a leading player in the industry, with a focus on developing therapeutics that can make a tangible difference in the lives of individuals suffering from these prevalent conditions.Generated from the website
United States›Washington›Seattle›Modulus Therapeutics, Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell